|
Rheumatoid Arthritis
Citations 171-180 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- BOOK REVIEWS
CONTEMPORARY TARGETED THERAPIES IN RHEUMATOLOGY, Edited by J. S. Smolen and P. E. Lipsky.
- U. Müller-Ladner
Rheumatology 2008; 47: 1261.
[Extract]
[Full Text]
- BOOK REVIEWS
CURRENT RHEUMATOLOGY DIAGNOSIS & TREATMENT, 2ND Edn, Edited by J. Imboden, D. Hellmann and J. Stone.
- M. A. Khurshid
Rheumatology 2008; 47: 1262.
[Extract]
[Full Text]
- REVIEWS
Rheumatic conditions in human immunodeficiency virus infection
- U. A. Walker, A. Tyndall, and T. Daikeler
Rheumatology 2008; 47: 952-959.
[Abstract]
[Full Text]
- CLINICAL
Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis
- G. Westhoff, F. Buttgereit, E. Gromnica-Ihle, and A. Zink
Rheumatology 2008; 47: 980-984.
[Abstract]
[Full Text]
- CLINICAL
Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug
- K. L. Hyrich, M. Lunt, W. G. Dixon, K. D. Watson, D. P. M. Symmons, and on behalf of the BSR Biologics Register
Rheumatology 2008; 47: 1000-1005.
[Abstract]
[Full Text]
- CLINICAL
Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept
- J. C. Cole, T. Li, P. Lin, R. MacLean, and G. V. Wallenstein
Rheumatology 2008; 47: 1044-1050.
[Abstract]
[Full Text]
- CLINICAL
Most tumour necrosis factor inhibitor trials in rheumatology are undeservedly called ‘efficacy and safety’ trials: a survey of power considerations
- Y. Yazici, N. M. Adler, and H. Yazici
Rheumatology 2008; 47: 1054-1057.
[Abstract]
[Full Text]
- CLINICAL
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
- C. G. Grijalva, C. P. Chung, C. M. Stein, E. F. Mitchel, Jr, and M. R. Griffin
Rheumatology 2008; 47: 1061-1064.
[Abstract]
[Full Text]
[ Supplementary Data ]
- CLINICAL
Assessment of anti-TNF- efficacy in rheumatoid arthritis: is 3 months sufficient?
- J. M. Pocock, J. C. Vasconcelos, and A. J. K. Östör
Rheumatology 2008; 47: 1073-1076.
[Abstract]
[Full Text]
[ Supplementary Data ]
- CLINICAL
Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis
- H. Forsblad d’Elia, R. Pullerits, H. Carlsten, and M. Bokarewa
Rheumatology 2008; 47: 1082-1087.
[Abstract]
[Full Text]
|
|
